Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Misetionamide

Copy Product Info
😃Good
Catalog No. T72879Cas No. 856785-75-6
Alias GP-2250, GP2250

Misetionamide is an orally active oxathiazin-like compound that functions as a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibitor with antineoplastic activity, Misetionamide is widely used in cancer research to investigate metabolic reprogramming, glycolytic dependency, and metabolism-targeted anticancer therapeutic strategies.

Misetionamide

Misetionamide

Copy Product Info
😃Good
Purity: 99.65%
Catalog No. T72879Alias GP-2250, GP2250Cas No. 856785-75-6
Misetionamide is an orally active oxathiazin-like compound that functions as a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibitor with antineoplastic activity, Misetionamide is widely used in cancer research to investigate metabolic reprogramming, glycolytic dependency, and metabolism-targeted anticancer therapeutic strategies.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$189-In Stock
5 mg$479-In Stock
10 mg$778-In Stock
25 mg$1,470-In Stock
50 mg$1,980-In Stock
100 mg$2,500-In Stock
1 mL x 10 mM (in DMSO)$528-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.65%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Misetionamide is an orally active oxathiazin-like compound that functions as a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibitor with antineoplastic activity, Misetionamide is widely used in cancer research to investigate metabolic reprogramming, glycolytic dependency, and metabolism-targeted anticancer therapeutic strategies.
Targets&IC50
TNBC cells:0-2000 μM
In vitro
In TNBC cell lines, Misetionamide (0-2000 μM) induces cell death in a dose- and time-dependent manner (24-72 h) and inhibits cell proliferation within 12 hours. Treatment with Misetionamide (0-1000 μM, 18 h) triggers both apoptosis and necrosis [2].
SynonymsGP-2250, GP2250
Chemical Properties
Molecular Weight137.16
FormulaC3H7NO3S
Cas No.856785-75-6
SmilesO=S1(=O)NCOCC1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (583.26 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM7.2908 mL36.4538 mL72.9076 mL364.5378 mL
5 mM1.4582 mL7.2908 mL14.5815 mL72.9076 mL
10 mM0.7291 mL3.6454 mL7.2908 mL36.4538 mL
20 mM0.3645 mL1.8227 mL3.6454 mL18.2269 mL
50 mM0.1458 mL0.7291 mL1.4582 mL7.2908 mL
100 mM0.0729 mL0.3645 mL0.7291 mL3.6454 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Misetionamide | purchase Misetionamide | Misetionamide cost | order Misetionamide | Misetionamide chemical structure | Misetionamide in vitro | Misetionamide formula | Misetionamide molecular weight